Log in to save to my catalogue

The significance of elevated tumor markers among patients with interstitial lung diseases

The significance of elevated tumor markers among patients with interstitial lung diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_28308650a9b2406397954b0278162a3a

The significance of elevated tumor markers among patients with interstitial lung diseases

About this item

Full title

The significance of elevated tumor markers among patients with interstitial lung diseases

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-10, Vol.12 (1), p.16702-16702, Article 16702

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The clinical implication of using serum tumor markers in patients with interstitial lung disease (ILD) is inconclusive. In this retrospective study, we analyzed the data of 1176 subjects (294 with ILDs and 882 healthy controls). Eligible patients were who had at least one or more available tumor marker results [carbohydrate antigen (CA) 19-9, CA 12...

Alternative Titles

Full title

The significance of elevated tumor markers among patients with interstitial lung diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_28308650a9b2406397954b0278162a3a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_28308650a9b2406397954b0278162a3a

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-20683-w

How to access this item